Questions for 9/28
1. For new drugs, how do let the consumers know of long term side effects when sometimes they've only been testing for 8-10 years and do not know the lifetime side effects?
2. Do companies have to keep testing and observing the drug for as long as it's on the market?
3. Is there a shortage of drugs from pharmaceutical companies because of the barrier to entry?
4. How many drugs can a company be working on at a time, or do they focus their attention to only one because it is timely and costly?
5. What are the legal effects in clinical testing if a person were to die? Is the person responsible for assumption of risk, or is the company held liable?
2. Do companies have to keep testing and observing the drug for as long as it's on the market?
3. Is there a shortage of drugs from pharmaceutical companies because of the barrier to entry?
4. How many drugs can a company be working on at a time, or do they focus their attention to only one because it is timely and costly?
5. What are the legal effects in clinical testing if a person were to die? Is the person responsible for assumption of risk, or is the company held liable?
Comments
Post a Comment